Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox

BACKGROUND: Iron overload, resulting from blood transfusions in patients with chronic anemias, has historically been controlled with regular deferoxamine, but its parenteral requirement encouraged studies of orally-active agents, including deferasirox and deferiprone. Deferasirox, licensed by the US...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivieri, Nancy F., Sabouhanian, Amir, Gallie, Brenda L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392256/
https://www.ncbi.nlm.nih.gov/pubmed/30811439
http://dx.doi.org/10.1371/journal.pone.0211942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392256/
https://www.ncbi.nlm.nih.gov/pubmed/30811439
http://dx.doi.org/10.1371/journal.pone.0211942

Ejemplares similares